• 1
    Feldman HA, Johannes CB, Derby CA et al. Erectile dysfunction and coronary risk factors: prospective results from the Massachusetts male aging study. Prev Med 2000; 30: 328338
  • 2
    Braun M, Wassmer G, Klotz T, Reifenrath B, Mathers M, Engelmann U. Epidemiology of erectile dysfunction: results of the ‘Cologne Male Survey’. Int J Impot Res 2000; 12: 305311
  • 3
    Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States. Prevalence and predictors. JAMA 1999; 281: 537544
  • 4
    Dunn KM, Croft PR, Hackett GI. Sexual problems: a study of prevalence and need for health care in the general population. Fam Pract 1998; 15: 519524
  • 5
    Thompson IM, Tangen CM, Goodman PJ, Probstfield JL, Moinpour CM, Coltman CA. Erectile dysfunction and subsequent cardiovascular disease. JAMA 2005; 294: 29963002
  • 6
    Litwin MS, Nied RJ, Dhanani N. Health-related quality of life in men with erectile dysfunction. J Gen Intern Med 1998; 13: 159166
  • 7
    Speel TGW, van Langen H, Meuleman EJH. The risk of coronary heart disease in men with erectile dysfunction. Eur Urol 2003; 44: 366371
  • 8
    Wilson EC, McKeen ES, Scuffham PA, Brown MC, Wylie K, Hackett G. The cost to the United Kingdom National Health Service of managing erectile dysfunction: the impact of sildenafil and prescribing restrictions. Pharmcoeconomics 2002; 20: 879889
  • 9
    British Society for Sexual Medicine. Guidelines on the management of erectile dysfunction. 2007. Available at: Accessed 3 February 2012
  • 10
    Sullivan ME, Keoghane SR, Miller MAW. Vascular risk factors and erectile dysfunction. BJU Int 2001; 87: 838845
  • 11
    Fung MM, Bettencourt R, Barrett-Connor E. Heart disease risk factors predict erectile dysfunction 25 years later. The Rancho Bernardo Study. J Am Coll Cardiol 2004; 43: 14051411
  • 12
    Tikkanen MJ, Jackson G, Tammela T et al. Erectile dysfunction as a risk factor for coronary heart disease: implications for prevention. Int J Clin Pract 2007; 61: 265268
  • 13
    Billups KL, Bank AJ, Padma-Nathan H, Katz S, Williams R. Erectile dysfunction is a marker for cardiovascular disease: results of the Minority Health Institute Expert Advisory Panel. J Sex Med 2005; 2: 4052
  • 14
    Walczak MK, Lokhandwala N, Hodge MB, Guay AT. Prevalence of cardiovascular risk factors in erectile dysfunction. J Gend Specif Med 2002; 5: 1924
  • 15
    Tsunekawa T, Hayashi T, Kano H et al. Cerivastatin, a hydroxymethylglutaryl coenzyme a reductase inhibitor, improves endothelial function in elderly diabetic patients within 3 days. Circulation 2001; 104: 376379
  • 16
    Saltzman EA, Guay AT, Jacobson J. Improvement in erectile dysfunction in men with organic erectile dysfunction by correlation of elevated cholesterol levels: a clinical observation. J Urol 2004; 172: 255258
  • 17
    Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol 1994; 151: 5461
  • 18
    Montorsi P, Montorsi F, Schulman CC. Is erectile dysfunction the ‘tip of the iceberg’ of a systemic vascular disorder? Eur Urol 2003; 44: 352354
  • 19
    Moore RA. Sildenafil (Viagra) for male erectile dysfunction: a meta-analysis of clinical trial reports. BMC Urol 2002; 2: 6. doi:10.1186/1471-2490-2-6
  • 20
    Masumoto A, Hirooka Y, Hironaga K et al. Effect of pravastatin on endothelial function in patients with coronary artery disease (cholesterol-independent effect of pravastatin). Am J Cardiol 2001; 88: 12911294
  • 21
    Herrmann HC, Levine LA, Macaluso J Jr et al. Can atorvastatin improve the response to sildenafil in men with erectile dysfunction not initially responsive to sildenafil? Hypothesis and Pilot Trial Results. J Sex Med 2006; 3: 303308
  • 22
    Yaman O, Akand M, Gursoy A, Erdogan MF, Anafarta K. The effect of diabetes mellitus treatment and good glycaemic control on the erectile function in men with diabetes mellitus-induced erectile dysfunction: a pilot study. J Sex Med 2006; 3: 344348
  • 23
    Gokkaya SC, Ozden C, Levent Ozdal O, Hakan Koyuncu H, Guzel O, Memis A. Effect of correcting serum cholesterol levels on erectile function in patients with vasculogenic erectile dysfunction. Scand J Urol Nephrol 2008; 42: 437440
  • 24
    Trivedi D, Kirby M, Norman F, Przybytniak I, Ali S, Wellsted DM. Can simvastatin improve erectile function and health-related quality of life in men aged > 40 years with erectile dysfunction? Rationale and design of the Erectile Dysfunction and Statins (EDS) Trial [ISRCTN66772971]. BJU Int 2011; 108: 18501854
  • 25
    Rosen RC, Cappelleri JC, Smith MD, Lipsky J, Pena BM. Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile function. Int J Impot Res 1999; 11: 319326
  • 26
    Wagner TH, Patrick DL, McKenna SP, Froese PS. Cross-cultural development of a quality of life measure for men with erection difficulties. Qual Life Res 1996; 5: 443449
  • 27
    Brooks R , Rabin R, de Charro F eds. The Measurement and Valuation of Health Status Using EQ-5D: A European Perspective: Evidence from the EuroQol BIO MED Research Programme. Rotterdam: Kluwer Academic Publishers, 2003
  • 28
    McEniery CM, Wallace S, Mackenzie IS et al. Endothelial function is associated with pulse pressure, pulse wave velocity and augmentation index in healthy humans. Hypertension 2006; 48: 602608
  • 29
    Baigent C, Landray MJ, Reith C et al. SHARP collaborators). The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial. Lancet 2011; 377: 21812192
  • 30
    Gupta BP, Murad H, Clifton M, Prokop L, Nehra A, Kopecky SL. The effect of lifestyle modification and cardiovascular risk factor reduction on erectile dysfunction. A systematic review and meta-analysis. Arch Intern Med 2011; 171: 17971803
  • 31
    Koskimaki J, Shiri R, Tammela T, Häkkinen J, Hakama M, Auvinen A. Regular intercourse protects against erectile dysfunction: Tampere Aging Male Urologic Study. Am J Med 2008; 121: 592596
  • 32
    JBS2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice. Heart 2005; 91 (Suppl. 5): V152
  • 33
    Shores MM, Matsumoto AM, Sloan KL, Kivlahan DR. Low serum testosterone and mortality in male veterans. Arch Intern Med 2006; 166: 16601665
  • 34
    Khaw KT, Dowsett M, Folkerd E et al. Endogenous testosterone and mortality due to all causes, cardiovascular disease, and cancer in men: European prospective investigation into cancer in Norfolk (EPIC-Norfolk) Prospective Population Study. Circulation 2007; 116: 26942701
  • 35
    Stanworth RD, Kapoor D, Channer KS, Hugh Jones T. Statin therapy is associated with lower total but not bioavailable or free testosterone in men with type 2 diabetes. Diabetes Care 2009; 32: 541546